Portal de Periódicos da CAPES

Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp

1993; Wiley; Volume: 100; Issue: 4 Linguagem: Inglês

10.1111/j.1471-0528.1993.tb12986.x

1471-0528

Austin Ugwumadu, David Bower, PC Ho,

Endometrial and Cervical Cancer Treatments

BJOG: An International Journal of Obstetrics & GynaecologyVolume 100, Issue 4 p. 386-388 Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp Austin H. N. Ugwumadu, Corresponding Author Austin H. N. Ugwumadu Senior House Officer in Obstetrics & Gynaecology Dr A. Ugwumadu, Department of Gynaecology, 5th Floor, Westminster Hospital, Dean Ryle Street, Horseferry Road, London SW1P 2AP, UK.Search for more papers by this authorDavid Bower, David Bower Consultant Obstetrician & Gynaecologist Search for more papers by this authorPhilip Kin-Hoi Ho, Philip Kin-Hoi Ho Lecturer in Obstetrics & Gynaecology Search for more papers by this author Austin H. N. Ugwumadu, Corresponding Author Austin H. N. Ugwumadu Senior House Officer in Obstetrics & Gynaecology Dr A. Ugwumadu, Department of Gynaecology, 5th Floor, Westminster Hospital, Dean Ryle Street, Horseferry Road, London SW1P 2AP, UK.Search for more papers by this authorDavid Bower, David Bower Consultant Obstetrician & Gynaecologist Search for more papers by this authorPhilip Kin-Hoi Ho, Philip Kin-Hoi Ho Lecturer in Obstetrics & Gynaecology Search for more papers by this author First published: April 1993 https://doi.org/10.1111/j.1471-0528.1993.tb12986.xCitations: 26Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Boccardo F., Buzzi P., Ruhagatti A., Nicolo G. & Rosso R. (1981) Oestrogen-like actions of Tamoxifen on vaginal epithelium in breast cancer patients, Oncol 38, 281–289. Cano A. et al. (1989) Tamoxifen and the uterus and the endometrium. Lancet i, 376–000. Clark J. H. & Peck E. J. (1979) Control of steroid receptor levels and steroid antagonism. In Female Sex Steroids, Receptors and Function ( J. H. Clark & E. J. Peck, ed), Springer Verlag, Berlin , pp. 99–134. Corley D. et al. (1992) Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 79 (1), 111–116. De Muylder X. et al. (1991) Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Obstet 36 (2), 127–130. de Waard F. (1982) Uterine corpus. In Cancer Epidemiology and Prevention, ( D. Schottenfield & J. F. Fraumeni, eds). W. F. Saunders, Philadelphia , pp. 901–908. Ferrazzi E. et al. (1977) Oestrogen-like effects of tamoxifen on vaginal epithelium. Br Med J i, 1351–1352. Ford M. et al. (1988) Endometriosis developing during tamoxifen therapy. Am J Obstet Gynaecol 58, 1119–0000. Fornander T. et al. (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet i, 117–120. Gorski J. et al. (1986) Evolution of a model of estrogen action. Rec Prog Hor Res 42, 297–329. Gottardis M. M. et al. (1988) Contrasting actions of tamoxifen on endometrial and breast tumour growth in the athymic mouse. Cancer Res 48, 812–815. Hsueh A. J. W., Peck E. J. & Clark J. H. (1975) Progesterone antagonism of the oestrogen receptor and oestrogen induced uterine growth. Nature 254, 337–339. King R. J. B. (1987) Structure and function of steroid receptors. J Endocrin 114, 341–349. King W. J. & Greene G. L. (1984) Monoclonal antibodies localise oestrogen receptor in the nuclei of target cells. Nature 307, 745–747. Kokko E. et al. (1982) Effects of tamoxifen, medroxyprogesterone acetate, and their combination on human endometrial oestrogen and progestin receptor concentrations, 17 beta-hydroxysteroid dehydrogenase activity and serum hormone concentrations. Am J Obstet Gynecol 143, 382–388. Le Bouedec G., Kauffmann P. & Pingeon J. M. (1991) Postmenopausal endometriosis developed during tamoxifen treatment. Rev Fr Gynaecol Obstet (French) 86 (5), 407–410. Mouridsen H. T., Ellemann K. & Mattsson W. (1979) Therapeutic effects of tamoxifen vs tamoxifen combined with medroxyprogesterone acetate in advanced breast cancer in postmenopausal women. Cancer Treat Rep 63, 171–175. Muldoon T. G. (1985) Steroid hormone receptor dynamics: the key to tissue responsiveness. In Molecular Mechanism of Steroid Hormone Action ( V. K. Modugdil, ed). Walter de Gruyter & Co., Berlin , pp. 173–197. Nayfield S. G. et al. (1991) Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83, 1450–1459. Neven P. et al. (1989) Tamoxifen and the uterus and the endometrium. Lancet i, 375–000. Neven P. et al. (1990) Hysteroscopic follow up during tamoxifen treatment. Eur J Obstet Gynecol Reprod Biol 35, 235–238. Nuovo M. A. et al. (1989) Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol 8, 125–131. Robertson W. B. (1981) The Endometrium. Butterworths & Co., London , pp. 65–70. Walters M. R. (1985) Steroid hormone receptors and the nucleus. Endocrin Rev 6, 5121. Weiss D. J. & Gurpide E. (1988) Non genomic effects of oestrogens and antioestrogens. J Steroid Biochem 31, 671–676. Welshons W. V., Lieberman M. E. & Gorski J. (1984) Nuclear localization of unoccupied oestrogen receptors. Nature 307, 747–749. Citing Literature Volume100, Issue4April 1993Pages 386-388 ReferencesRelatedInformation